Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / CHV Management, LLC

CHV Management, LLC

Institutional venture firmBoston, MAchv.vcSEC venture capital fund adviserone firm, 2 filing advisers

This firm files as 2 advisers on chv.vc: Chtp Management Services Inc.. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

Catalyst Health Ventures (CHV) is a Boston-based medtech VC firm backing early-stage healthcare technology founders since 2008.

venture manager, reported GAV $132M across 6 vehicles

Importance
23
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
11
low
Identity and regulatory footprint
Headquarters
Boston, MAadviserinfo.sec.gov
Office address
129 SOUTH STREET, 4TH FLOOR, Boston, MA, 02111adviserinfo.sec.gov
Business phone
781-228-5228adviserinfo.sec.gov
Website
http://chv.vc
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 26, 2026
Private funds reported
6 (6 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$164Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
The Joshua S. Phillips Living Trust Dated July 16, 2020 (Member, Catalyst Health Ventures Gp Iii, Llc), D
business phone
781-228-5228adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
medtech
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
6 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Catalyst Health Ventures Fund III, L.P.Fund2023 adv first reportedActive deployment$50.0M
Mar 14, 2024
23$0
of $125M
Sep 22, 2022
Catalyst Health Ventures Partners Fund III, L.P.Fund2023 adv first reportedActive deployment$4.6M
Mar 14, 2024
6$0
of $10.0M
Sep 22, 2022
CHV Spv Iii-A, L.P.SPV or co-invest vehicle2023 adv first reportedActive deployment$934,573
Mar 14, 2024
6$0
of $1.0M
Dec 14, 2022
CHV Spv I, LPSPV or co-invest vehicle2020 form d first saleMature$1.4M
Mar 14, 2024
36$1.1M
of $1.1M
Dec 22, 2020
Catalyst Health Ventures IV, L.P.Fund2018 form d first saleHarvest$62.2M
Mar 14, 2024
49$66.6M
of $100M
Oct 20, 2020
CHV Partners Fund IV, L.P.Fund2018 form d first saleHarvest$12.9M
Mar 14, 2024
26$66.6M
of $100M
Oct 20, 2020
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
6 current, 0 departed
Kimberly Phillips
Trustee · since Jul 1, 2020
Board or advisory
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Darshana Zaveri
Member And Manager, Catalyst Health Ventures Gp Iii, Llc · since Jun 1, 2022
General partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Joshua S Phillips
Manager, Catalyst Health Ventures Gp Iii, Llc · since Jun 1, 2022
General partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Kevin Mccafferty
Member, Chv Management Llc · since Jul 1, 2020
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Robert Vigoda
Member, Chv Management Llc · since Jul 1, 2020
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
David Hamilton Mackey
Chief Financial Officer, Chv Management Llc · since Oct 1, 2021
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
2 relationships from shared deals, counted for the whole firm
Ascension Ventures 1 shared · one timeDelos Advisors, Inc. 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
11 dated events
  1. Mar 22, 2023
    Catalyst Health Ventures Fund III, L.P. first reported on Form ADV by CHV Management, LLC (Venture Capital Fund), GAV $46,212,289
    Fund first reported on Form ADVFundsFactCatalyst Health Ventures Fund III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 22, 2023
    CHV Spv Iii-A, L.P. first reported on Form ADV by CHV Management, LLC (Venture Capital Fund), GAV $977,492
    Fund first reported on Form ADVFundsFactCHV Spv Iii-A, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Mar 22, 2023
    Catalyst Health Ventures Partners Fund III, L.P. first reported on Form ADV by CHV Management, LLC (Venture Capital Fund), GAV $4,645,070
    Fund first reported on Form ADVFundsFactCatalyst Health Ventures Partners Fund III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Oct 1, 2021
    David Hamilton Mackey joined Schedule A of CHV Management, LLC as Chief Financial Officer, Chv Management Llc
    Person joinedPeopleFactDavid Hamilton MackeySEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Mar 31, 2021
    CHV Spv I, LP first reported on Form ADV by CHV Management, LLC (Venture Capital Fund), GAV $1,040,455
    Fund first reported on Form ADVFundsFactCHV Spv I, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Jul 1, 2020
    Robert Vigoda joined Schedule A of CHV Management, LLC as Member, Chv Management Llc
    Person joinedPeopleFactRobert VigodaSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Jul 1, 2020
    Kevin Mccafferty joined Schedule A of CHV Management, LLC as Member, Chv Management Llc
    Person joinedPeopleFactKevin MccaffertySEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Jul 1, 2020
    Kimberly Phillips joined Schedule A of CHV Management, LLC as Trustee
    Person joinedPeopleFactKimberly PhillipsSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Apr 17, 2019
    CHV Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Apr 17, 2019
    Catalyst Health Ventures IV, L.P. first reported on Form ADV by CHV Management, LLC (Venture Capital Fund), GAV $22,800,000
    Fund first reported on Form ADVFundsFactCatalyst Health Ventures IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Apr 17, 2019
    CHV Partners Fund IV, L.P. first reported on Form ADV by CHV Management, LLC (Venture Capital Fund), GAV $9,000,000
    Fund first reported on Form ADVFundsFactCHV Partners Fund IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $132M across 6 vehicles
Evidence
47 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2019-04-17Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-26Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-14Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2019-04-17Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone781-228-5228Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone781-228-5228Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://chv.vc/contact/
“contact page linked from the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionCatalyst Health Ventures (CHV) is a Boston-based medtech VC firm backing early-stage healthcare technology founders since 2008.
“meta description”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionCatalyst Health Ventures (CHV) is a Boston-based medtech VC firm backing early-stage healthcare technology founders since 2008.
“meta description”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersBoston, MAMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersBoston, MAMar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address129 SOUTH STREET, 4TH FLOOR, Boston, MA, 02111Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address129 SOUTH STREET, 4TH FLOOR, Boston, MA, 02111Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
“Catalyst Health Ventures | Medtech Venture Capital @font-face{font-family:'trx_addons_icons';src:url(//chv.”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Self-described typeventure_capital
“Catalyst Health Ventures | Medtech Venture Capital @font-face{font-family:'trx_addons_icons';src:url(//chv.”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formLimited Liability CompanyMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://chv.vc/portfolios/
“0 entries read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://chv.vc/portfolios/
“0 entries read”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported6Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported6Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$164MMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$132MMar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorsmedtech
“sector words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsmedtech
“sector words on the home page”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://chv.vc/chv-team/
“0 name/title pairs read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://chv.vc/chv-team/
“0 name/title pairs read”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported6Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported6Mar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttp://chv.vcMar 14, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleCatalyst Health Ventures | Medtech Venture Capital
“title tag”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleCatalyst Health Ventures | Medtech Venture Capital
“title tag”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)